共 70 条
[1]
Spiess PE(2017)Bladder cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology J Natl Comp Canc Netw 15 1240-1267
[2]
Agarwal N(2003)Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859-866
[3]
Bangs R(2005)Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 202-205
[4]
Grossman HB(2005)Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) meta-analysis Collaboration Eur Urol 48 189-199
[5]
Natale RB(2011)Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Cancer 117 276-282
[6]
Tangen CM(2014)Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database Urology 83 75-80
[7]
Raj GV(2014)Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions Adv Urol 2014 746298-e858
[8]
Karavadia S(2018)Optimization of patient selection for neoadjuvant chemotherapy in muscle-invasive urothelial carcinoma of the bladder Clin Genitourin Cancer 16 e851-611
[9]
Schlomer B(2015)Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: predicting response and assessing outcomes Urol Oncol 33 204-383
[10]
Zaid HB(2017)Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study BJU Int 119 605-213